Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of mitapivat versus placebo on transfusion burden in patients with sickle cell disease
BelgiumStudy on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49
BelgiumStudy of Human Normal Immunoglobulin in Adults with Secondary Immune Deficiency after CAR T‑cell or T‑cell Redirecting Therapy for Hematologic Malignancies
BelgiumRandomized trial of standard vs high-dose enoxaparin and sodium chloride for preventing clots in critically ill ICU patients at high risk of thrombosis
BelgiumA Randomized, Double‑Blind, Placebo‑Controlled Study of Momelotinib Dihydrochloride Monohydrate in Patients with VEXAS Syndrome
BelgiumDiagnostic PET/CT Study with [AL[18F]F]FAPI-74 in Psoriasis Patients with Arthralgia for Early Detection of Psoriatic Arthritis
BelgiumA Phase 2 Study Evaluating the Safety and Efficacy of Oral NS-863 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease
BelgiumStudy of epcoritamab, venetoclax and ibrutinib in treatment‑naïve chronic lymphocytic leukemia patients with TP53 alterations
BelgiumA Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
BelgiumSafety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH
BelgiumStudy of setidegrasib (ASP3082) and docetaxel in patients with KRAS G12D‑mutated advanced/metastatic NSCLC after platinum chemo and checkpoint inhibitor
BelgiumStudy of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
